Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397872
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-07
First Post:
2024-04-30
Brief Title:
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Multiple Oral Doses 6 Days of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function
Sponsor:
Madrigal Pharmaceuticals Inc
Organization:
Madrigal Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
April 30 2024
Study First Post Date:
2024-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-03
Last Update Post Date:
2024-05-07
Last Update Post Date Type:
ACTUAL